{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:03:45Z","timestamp":1781715825831,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2018,5,22]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Alzheimer's Disease (AD) is an age-related neurodegenerative disorder characterized\nby progressive cognitive impairments and chronic inflammation that affects over 30\nmillion people all over the world. Most of the Alzheimer's patients also suffer from psychosis,\naggression, agitation, depression, anxiety, and many other behavioral and psychological\nsymptoms of dementia. Unfortunately, the currently available anti-AD drugs provide modest\nsymptomatic relief, and they do not reverse the neurodegeneration. Therefore, the average\nlife expectancy after diagnosis is between six and ten years. Research data suggest that\nmulti-target-directed ligands (MTDLs) give an opportunity to prevent, halt, or reverse the\nprogression of AD, and reduce the symptoms of the disease. The aim of this review is to\nupdate the most recent reports on the development of MTDLs affecting serotonergic neurotransmission\nas potential drugs for both symptomatic and disease-modifying therapy of AD.\nMultifunctional modulators of serotonergic system exerted procognitive, antipsychotic, antidepressant,\nand\/or anxiolytic properties in preclinical studies. Some of them revealed their\npotential as modulators of tau phosphorylation or amyloid beta aggregation with neuroprotective,\nanti-inflammatory, and\/or antioxidant properties. Among them, lumateperone - an\ninhibitor of serotonin transporter with a high affinity for serotonergic and dopaminergic receptors\nis currently being tested in clinical trials in patients with dementia, bipolar depression,\nor schizophrenia. The high therapeutic potential of MTDLs as anti-AD drugs seems to\nbe the result of their involvement in multiple neurotransmitter systems and intracellular signaling\npathways.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867324666170529122802","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T08:07:35Z","timestamp":1496131655000},"page":"2045-2067","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer\u2019s Disease Therapy: Advances in Chemical and Biological Research"],"prefix":"10.2174","volume":"25","author":[{"given":"Agnieszka","family":"Jankowska","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wesolowska","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pawlowski","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Chlon-Rzepa","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/152754","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/152754\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/152754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T09:58:37Z","timestamp":1608890317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/152754\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,5,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867324666170529122802","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"1970-01-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}